Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future
Peripheral nerve injuries are a prevalent global issue that has garnered great concern. Although autografts remain the preferred clinical approach to repair, their efficacy is hampered by factors like donor scarcity. The emergence of nerve guidance conduits as novel tissue engineering tools offers a...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-04-01
|
Series: | Materials Today Bio |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006425000614 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823859394588180480 |
---|---|
author | Chundi Liu Mouyuan Sun Lining Lin Yaxian Luo Lianjie Peng Jingyu Zhang Tao Qiu Zhichao Liu Jun Yin Mengfei Yu |
author_facet | Chundi Liu Mouyuan Sun Lining Lin Yaxian Luo Lianjie Peng Jingyu Zhang Tao Qiu Zhichao Liu Jun Yin Mengfei Yu |
author_sort | Chundi Liu |
collection | DOAJ |
description | Peripheral nerve injuries are a prevalent global issue that has garnered great concern. Although autografts remain the preferred clinical approach to repair, their efficacy is hampered by factors like donor scarcity. The emergence of nerve guidance conduits as novel tissue engineering tools offers a promising alternative strategy. This review aims to interpret nerve guidance conduits and their commercialization from both clinical and laboratory perspectives. To enhance comprehension of clinical situations, this article provides a comprehensive analysis of the clinical efficacy of nerve conduits approved by the United States Food and Drug Administration. It proposes that the initial six months post-transplantation is a critical window period for evaluating their efficacy. Additionally, this study conducts a systematic discussion on the research progress of laboratory conduits, focusing on biomaterials and add-on strategies as pivotal factors for nerve regeneration, as supported by the literature analysis. The clinical conduit materials and prospective optimal materials are thoroughly discussed. The add-on strategies, together with their distinct obstacles and potentials are deeply analyzed. Based on the above evaluations, the development path and manufacturing strategy for the commercialization of nerve guidance conduits are envisioned. The critical conclusion promoting commercialization is summarized as follows: 1) The optimization of biomaterials is the fundamental means; 2) The phased application of additional strategies is the emphasized direction; 3) The additive manufacturing techniques are the necessary tools. As a result, the findings of this research provide academic and clinical practitioners with valuable insights that may facilitate future commercialization endeavors of nerve guidance conduits. |
format | Article |
id | doaj-art-54226e80c0494e5fbe89e8b5b1fee1b3 |
institution | Kabale University |
issn | 2590-0064 |
language | English |
publishDate | 2025-04-01 |
publisher | Elsevier |
record_format | Article |
series | Materials Today Bio |
spelling | doaj-art-54226e80c0494e5fbe89e8b5b1fee1b32025-02-11T04:35:21ZengElsevierMaterials Today Bio2590-00642025-04-0131101503Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and futureChundi Liu0Mouyuan Sun1Lining Lin2Yaxian Luo3Lianjie Peng4Jingyu Zhang5Tao Qiu6Zhichao Liu7Jun Yin8Mengfei Yu9Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, China; Corresponding author.Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaThe State Key Laboratory of Fluid Power and Mechatronic Systems, Key Laboratory of 3D Printing Process and Equipment of Zhejiang Province, School of Mechanical Engineering, Zhejiang University, Hangzhou, 310027, China; Corresponding author.Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, China; Corresponding author.Peripheral nerve injuries are a prevalent global issue that has garnered great concern. Although autografts remain the preferred clinical approach to repair, their efficacy is hampered by factors like donor scarcity. The emergence of nerve guidance conduits as novel tissue engineering tools offers a promising alternative strategy. This review aims to interpret nerve guidance conduits and their commercialization from both clinical and laboratory perspectives. To enhance comprehension of clinical situations, this article provides a comprehensive analysis of the clinical efficacy of nerve conduits approved by the United States Food and Drug Administration. It proposes that the initial six months post-transplantation is a critical window period for evaluating their efficacy. Additionally, this study conducts a systematic discussion on the research progress of laboratory conduits, focusing on biomaterials and add-on strategies as pivotal factors for nerve regeneration, as supported by the literature analysis. The clinical conduit materials and prospective optimal materials are thoroughly discussed. The add-on strategies, together with their distinct obstacles and potentials are deeply analyzed. Based on the above evaluations, the development path and manufacturing strategy for the commercialization of nerve guidance conduits are envisioned. The critical conclusion promoting commercialization is summarized as follows: 1) The optimization of biomaterials is the fundamental means; 2) The phased application of additional strategies is the emphasized direction; 3) The additive manufacturing techniques are the necessary tools. As a result, the findings of this research provide academic and clinical practitioners with valuable insights that may facilitate future commercialization endeavors of nerve guidance conduits.http://www.sciencedirect.com/science/article/pii/S2590006425000614Nerve guidance conduitPeripheral nerveClinical efficacyBiomaterialAdd-on strategy |
spellingShingle | Chundi Liu Mouyuan Sun Lining Lin Yaxian Luo Lianjie Peng Jingyu Zhang Tao Qiu Zhichao Liu Jun Yin Mengfei Yu Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future Materials Today Bio Nerve guidance conduit Peripheral nerve Clinical efficacy Biomaterial Add-on strategy |
title | Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future |
title_full | Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future |
title_fullStr | Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future |
title_full_unstemmed | Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future |
title_short | Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future |
title_sort | potentially commercializable nerve guidance conduits for peripheral nerve injury past present and future |
topic | Nerve guidance conduit Peripheral nerve Clinical efficacy Biomaterial Add-on strategy |
url | http://www.sciencedirect.com/science/article/pii/S2590006425000614 |
work_keys_str_mv | AT chundiliu potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture AT mouyuansun potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture AT lininglin potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture AT yaxianluo potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture AT lianjiepeng potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture AT jingyuzhang potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture AT taoqiu potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture AT zhichaoliu potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture AT junyin potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture AT mengfeiyu potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture |